72 Systemic administration of IL-15 augments primary T cell response to vaccination
Mark P. Rubinstein, Andre N. Kadima, Mohamed L. Salem, Christophe L. Nguyen, William E. Gillanders, and David J. Cole
Medical University of South Carolina; Charleston, SC
73 Prolactin Promotes Mammary Tumor Growth in C3(1)/SV40 Large T-Antigen Transgenic Mice
Welniak, Lisbeth1; Hixon, Julie2; Richards, Susan3; Green, Jeffrey4; Murphy, William21Laboratory of Molecular Immunoregulation, National Cancer Institute – Frederick, Frederick, MD; 2IRSP, SAIC, NCI- Frederick Frederick, MD; 3Genzyme Corporation Framingham, MA; 4LCRC, National Cancer Institute Bethesda, MD
74 Down modulation of host innate immune responses by RanC/d with adenoviral gene therapy
Peter M C Wong, John A Arnott & Siu-Wah Chung
Department of Pathology & Laboratory Medicine, Fels Institute of Cancer Research & Molecular Biology, Temple University School of Medicine, Philadelphia, PA
75 Therapeutic efficacy of vitamin D3-binding protein-derived macrophage activating factor for prostate, breast and colon cancer
Nobuto Yamamoto1, Masahiro Urade2, Hirofumi Suyama3, and Hiroaki Nakazato41Socrates Institute for Therapeutic Immunology, Philadelphia, PA; 2Hyogo College of Medicine, Hyogo; 3Nagasaki University, Nagasaki; and 4Yokoyama Hospital, Nagoya, Japan
76 Delayed in vivo growth of Lewis lung carcinoma cells that have been genetically engineered to secrete the kringle 5 domain of plasminogen
Hiroshi Yazawa1, Philip G. Roessler1, Robert H. Wiltrout1 and Morihiro Watanabe11Laboratory of Experimental Immunology, NCI Center for Cancer Research, Frederick, MD
77 Tumor-lytic CD28-CD8+ T Cells Circulating in Patients with Ewing’s Sarcoma Derive Requisite Co-stimulation by Tumor Expression of 4-1BBL
Hua Zhang1, Kevin S Chua1, Chand Khanna2, Lee J Helman2 and Crystal L Mackall11Immunology Section, 2Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD
78 Novel Method to Simplify Detection and Functional Analysis of Antigen-Specific T cells
H-M. Hu, A. Dols, S.L. Meijer, J.W. Smith III, W.J. Urba, E. Walker, B.A.Fox
R.W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR
79 Identification of a New Candidate HLA-A3 Restricted CMV Epitope as a Target Antigen to induce specific CMV Cytotoxic T Lymphocyte
Jong-Baeck Lim, Maurizio Provenzano, Maria Bettinotti and David Stroncek
Department of Transfusion Medicine, Clinical Center, National Institute of Health, Bethesda, MD
80 Novel naturally processed MHC class I-bound peptides from ovarian and prostate cancer identified by mass spectrometry
Venky Ramakrishna, Helen Myers, Melanie McDaniel and Ramila Philip
Argonex Inc., Charlottesville, VA 22903
81 Anti-tumor Effects of Liposomal IL-2 in an MCA 38 Colon Liver Metastases Tumor Model
Mary H Ryan, Mary E Neville, Chad Hubbard, Richard J Robb and Mircea C Popescu
Biomira USA Inc., Cranbury NJ